Advanced Ophthalmic Systems Eyes Growth with New Funding Round

Advanced Ophthalmic Systems (AOS), a MedTech company specialising in pioneering and advanced software for the ophthalmic industry is the latest company to be supported by the Coast to Capital Growth Equity Fund. The Croydon based venture successfully completed the funding round which includes angel monies facilitated by The FSE Investor Network.

AOS has spent 3 years developing over 200+ algorithms and in the back end of last year they released their first digital analytics software product, AOS Anterior. The AOS Anterior automatically assesses multiple eye pathologies with Gold Standard accuracy & repeatability. The software has been developed to be visually informative and striking, allowing opticians to increase customer engagement and understanding during examinations, whilst decreasing the amount of time patients need to sit in the chair. All results are provided instantly, with simplified reporting to assist with future follow up visits and the in-built reporting function generates a fully customisable report for each patient.

The funding will enable AOS to expand its already impressive team in both the business development and product development departments. This will give the company the manpower it needs to cement itself as one of the leaders in the eye health sector.

Dr Eduardo Mangieri, CEO at Advanced Ophthalmic Systems, explains, “Our target is to provide innovative solutions in the ophthalmic market for the early detection and monitoring of various pathologies.  Our technology provides automatic ophthalmic diagnosis by delivering objective, digital imaging analytics during optical appointments. This increases patient understanding and more importantly reduces appointment times, leading to a far more punctual service.”

Avent Bezuidenhoudt, Senior Fund Manager at The FSE Group, “We are delighted to be supporting AOS in this funding round. The company have developed a state-of-the-art product that will have such a positive impact for current and future ophthalmic patients. We are excited to see what the future holds for Eduardo and his team and look forward to working with them to achieve their goals.”

The Coast to Capital Growth Equity Fund is part of the Coast to Capital Funding Escalator, a £5million initiative funded by Coast to Capital Local Enterprise Partnership. The escalator, which also includes an expansion loan scheme, provides eligible companies with loans and equity funding between £50,000 and £500,000 for activities that will deliver high-growth and employment opportunities across the Coast to Capital region.

For more information about the Coast to Capital Funding Escalator please visit http://www.thefsegroup.com/coast-capital-funding-escalator or contact Avent Bezuidenhoudt at avent.bezuidenhoudt@thefsegroup.com tel: 01276 608526.